This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
doi: 10.4103/0970-2113.343593
In the article titled “Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group”, published on pages 177-186, Issue 2, Volume 39 of Lung India[1], the third author’s name is incorrectly written as “Sahajal Dhoori.” The correct author’s name should read as “Sahajal Dhooria.”
The “How to cite this article” section should read correctly as ”Salvi SS, Ghorpade D, Dhooria S, Dhar R, Dumra H, Chhajed PN, et al. Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group. Lung India 2022;39:177-86”.
REFERENCE
1. Salvi SS, Ghorpade D, Dhoori S, Dhar R, Dumra H, Chhajed PN, et al. Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease:A review of literature and report from an expert working group Lung India 2022 39 177 86
